Total Funding
26
55
Total FundingGrant raised
Growth Score
-3 pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
107886
DC4U is a life science company that develops technologies enabling steering the human immune response.
- Ineke Rijnhout: CEO
- Henk Vietor: CMOPast Role: Oncodrone, Chief Executive Officer & Founder
About the Company
DC4U is a life science company that develops technologies enabling steering the human immune response. Its core expertise is the immunological application of glycobiology. Based on this knowledge a platform technology (GlycoDC) was developed which can modulate the immune system and can be applied to antigen based therapeutics and products.
Its
GlycoDCTM technology can either potentiate or suppress the immune system via specific targeting of dendritic cells by glycan modified antigen conjugates.
